REQUIREMENT OF GLYCOLYTIC SUBSTRATE FOR METABOLIC RECOVERY DURING MODERATE LOW-FLOW ISCHEMIA

被引:38
|
作者
SCHAEFER, S
PRUSSEL, E
CARR, LJ
机构
[1] University of California, Davis, Division of Cardiovascular Medicine TB 172, Davis
关键词
NMR SPECTROSCOPY; HIGH ENERGY PHOSPHATES; MYOCARDIAL METABOLISM; VIABLE MYOCARDIUM;
D O I
10.1016/S0022-2828(95)91407-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Low flow ischemia with stable hemodynamic function can result in partial metabolic recovery characterized by an increase in phosphocreatine (PCr), Prior data suggest that glycolytic production of adenosine triphosphate (ATP) may be critical for this recovery and that the ATP produced by oxidative phosphorylation alone may be insufficient. This study tested the hypotheses that, during moderate low flow ischemia, (a) metabolic recovery is dependent on glycolytic production of ATP, and, therefore, (b) a mitochondrial substrate such as pyruvate alone is inadequate to allow metabolic recovery. High energy phosphates, pH, and lactate release were measured during 2 h of moderate low now ischemia. Hearts were perfused with either a glycolytic plus mitochondrial substrate (glucose, insulin and pyruvate) or a mitochondrial substrate alone (pyruvate). Flow reductions required to reduce PCr by approximately 8% resulted in stable and equal reductions of rate-pressure product in each group. PCr recovered fully during the ischemic period in control hearts with glycolytic substrate, associated with preservation of normal end-diastolic pressure, and increased lactate release during the first hour of ischemia. Reperfusion of these hearts restored hemodynamic function and increased PCr above baseline values. In contrast, the use of pyruvate alone as a substrate resulted in a progressive fall of PCr during ischemia, increased end-diastolic pressure, and no significant increase in lactate release, Reperfusion in these hearts restored hemodynamic function, but did not result in normalization of PCr. Both groups had significant reductions in ATP during ischemia, Recovery of PCr during ongoing moderate low flow ischemia is observed in the presence of mixed glycolytic and mitochondrial substrates (glucose, insulin and pyruvate) but is not observed with pyruvate as a sole mitochondrial substrate. These data support a critical role for glycolytic nux under these conditions, suggesting that ATP generated solely by oxidative phosphorylation is not sufficient to promote metabolic recovery or maintain diastolic function during moderate low now ischemia. (C) 1995 Academic Press Limited
引用
收藏
页码:2167 / 2176
页数:10
相关论文
共 50 条
  • [21] Beneficial effects of felodipine on myocardial and coronary function during low-flow ischemia and reperfusion
    Bernstein, EA
    Eberli, FR
    Silverman, AM
    Horowitz, GL
    Apstein, CS
    CARDIOVASCULAR DRUGS AND THERAPY, 1996, 10 (02) : 167 - 178
  • [22] Protective effect of the sodium/hydrogen exchange inhibitors during global low-flow ischemia
    Khandoudi, N
    Laville, MP
    Bril, A
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (04) : 540 - 546
  • [23] Polymorphonuclear granulocytes induce myocardial dysfunction during ischemia and in later reperfusion of hearts exposed to low-flow ischemia
    Seligmann, C
    Bock, A
    Leitsch, T
    Schimmer, M
    Simsek, Y
    Schultheiss, HP
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, 69 (05) : 727 - 731
  • [24] METABOLIC AND PHYSIOLOGICAL DIFFERENCES BETWEEN ZERO-FLOW AND LOW-FLOW MYOCARDIAL ISCHEMIA - EFFECTS OF L-ACETYLCARNITINE
    PAULSON, DJ
    SCHMIDT, MJ
    ROMENS, J
    SHUG, AL
    BASIC RESEARCH IN CARDIOLOGY, 1984, 79 (05) : 551 - 561
  • [25] Low-flow vascular remodeling in the metabolic syndrome X
    Stepp, DW
    Pollock, DM
    Frisbee, JC
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (03): : H964 - H970
  • [26] β-hydroxybutyrate accumulates in the rat heart during low-flow ischaemia with implications for functional recovery
    Lindsay, Ross T.
    Dieckmann, Sophie
    Krzyzanska, Dominika
    Manetta-Jones, Dominic
    West, James A.
    Castro, Cecilia
    Griffin, Julian L.
    Murray, Andrew J.
    ELIFE, 2021, 10
  • [27] HSC73-tubulin complex formation during low-flow ischemia in the canine myocardium
    Decker, RS
    Decker, ML
    Nakamura, S
    Zhao, YS
    Hedjbeli, S
    Harris, KR
    Klocke, FJ
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (04): : H1322 - H1333
  • [28] COMPARISON OF FLUORINE-18-FLUORODEOXYGLUCOSE AND TRITIATED FLUOROMISONIDAZOLE UPTAKE DURING LOW-FLOW ISCHEMIA
    CALDWELL, JH
    REVENAUGH, JR
    MARTIN, GV
    JOHNSON, PM
    RASEY, JS
    KROHN, KA
    JOURNAL OF NUCLEAR MEDICINE, 1995, 36 (09) : 1633 - 1638
  • [29] EFFECTS OF OUABAIN AND ISOPROTERENOL ON DIASTOLIC DYSFUNCTION DURING LOW-FLOW ISCHEMIA IN ISOLATED RABBIT HEARTS
    CHODOS, AP
    LORELL, BH
    KONISHI, T
    GRICE, WN
    APSTEIN, CS
    CLINICAL RESEARCH, 1988, 36 (03): : A267 - A267
  • [30] INFLUENCE OF LOW-FLOW INFUSION AND MAGNESIUM ON TISSUE NECROSIS DURING REGIONAL ISCHEMIA IN THE CANINE MYOCARDIUM
    KINGMA, JG
    QIU, Y
    HEARSE, DJ
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (07) : 1004 - 1010